Medicine is moving farther from its fee-for-service roots and closer to more individualized, value-based care—a phenomenon that could benefit a growing number of home-based care programs, according to data presented at MedAxiom’s CV Transforum.
Research published in JACC: Heart Failure Nov. 6 uncovered a worrying statistic in cardiology: Older patients who are hospitalized for heart failure could experience as much as a 12% increase in the number of HF-exacerbating medications they’re prescribed between admission and hospital discharge.
The notion of a single-payer health system has been central to the 2020 presidential election, dominating much of the news cycle in recent months. According to an editorial published Nov. 4, that could be a good thing for physicians.
Remote monitoring and high-tech health management solutions have dominated cardiology headlines for the better part of the past year, touted for their accessibility and preventive benefits. But that vision of remote monitoring as the future of CV care might be a skewed representation of our current reality.
A cross-sectional study of heart patients undergoing ICD implantation revealed a marked decline in the use of defibrillation testing over time in the U.S., suggesting the precaution might be losing its value as a clinical tool.
As healthcare strives to be everywhere for every patient, clinicians may be on the fast track to burnout. Here’s how some practices are dispersing their teams to achieve quality care, efficient workflows and satisfied clinicians.
The past year has seen a whole lot of change for the field of cardiology, but it’s hard to discern where that leaves us as we prepare for 2020. MedAxiom President Jerry Blackwell, MD, MBA, helped clarify the situation.
Research out of Brigham and Women’s Hospital in Boston found heart failure patients who self-identify as black, Latinx or female are less likely to be admitted to the hospital’s cardiology department, suggesting admission bias might be a partial contributor to known racial disparities in HF outcomes.
The notion of a digital transformation in cardiology, and healthcare as a whole, is an appealing one. But data presented at MedAxiom’s CV Transforum last week suggests we’re further away from a transformation than we might think.